Nothing Special   »   [go: up one dir, main page]

ES2031892T3 - Agentes antialergicos y antiinflamatorios. - Google Patents

Agentes antialergicos y antiinflamatorios.

Info

Publication number
ES2031892T3
ES2031892T3 ES87304983T ES87304983T ES2031892T3 ES 2031892 T3 ES2031892 T3 ES 2031892T3 ES 87304983 T ES87304983 T ES 87304983T ES 87304983 T ES87304983 T ES 87304983T ES 2031892 T3 ES2031892 T3 ES 2031892T3
Authority
ES
Spain
Prior art keywords
allergic
alkyl
inflammatory agents
hydrogen
antiallergy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304983T
Other languages
English (en)
Inventor
Yoshihiko Kitaura
Fumitaka Ito
Rodney William Stevens
Nobuko Asai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Application granted granted Critical
Publication of ES2031892T3 publication Critical patent/ES2031892T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)

Abstract

COMPUESTOS DE LA FORMULA (I) DONDE Y ES ALQUILO, ARILO O HETEROCICLICOS, N ES 1-7, R ES HIDROGENO, ALQUILO, ARALQUILO O CARBOXIMETILO, R1 ES HIDROGENO, HALO, ALQUILO, ALCOXI O TRIFLUOROMETILO, R2 ES HIDROGENO, ALQUILO O ALCANOILO Y X ES C=0, CH2, NH, O O S COMO AGENTES ANTIALERGICOS Y ANTIINFLAMATORIOS.
ES87304983T 1986-06-09 1987-06-05 Agentes antialergicos y antiinflamatorios. Expired - Lifetime ES2031892T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13347086 1986-06-09

Publications (1)

Publication Number Publication Date
ES2031892T3 true ES2031892T3 (es) 1996-07-16

Family

ID=15105525

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304983T Expired - Lifetime ES2031892T3 (es) 1986-06-09 1987-06-05 Agentes antialergicos y antiinflamatorios.

Country Status (21)

Country Link
EP (1) EP0249407B1 (es)
JP (1) JPH0623199B2 (es)
KR (1) KR900000552B1 (es)
CN (1) CN1015334B (es)
AT (1) ATE60596T1 (es)
AU (1) AU586337B2 (es)
CA (1) CA1305151C (es)
DD (1) DD265141A5 (es)
DE (1) DE3767778D1 (es)
DK (1) DK288287A (es)
ES (1) ES2031892T3 (es)
FI (1) FI87924C (es)
GR (1) GR3001584T3 (es)
HU (1) HU198451B (es)
IE (1) IE60015B1 (es)
NO (1) NO168246C (es)
PL (1) PL150631B1 (es)
PT (1) PT85035B (es)
SU (1) SU1757464A3 (es)
YU (1) YU45423B (es)
ZA (1) ZA874046B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720297A (en) * 1985-09-27 1988-01-19 Sumitomo Chemical Company, Limited Benzothiazolones, and their production and use as herbicides
JPH0283376A (ja) * 1988-09-19 1990-03-23 Pfizer Pharmaceut Co Ltd ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物
IL93473A0 (en) * 1989-02-28 1990-11-29 Pfizer Antiinflammatory benzoxazolones
JPH0678327B2 (ja) * 1989-07-20 1994-10-05 ファイザー製薬株式会社 ４，５，６，７，―四置換ベンゾオキサゾロン類
JPH0729998B2 (ja) * 1990-01-22 1995-04-05 ファイザー製薬株式会社 新規ベンゾキノン化合物およびその組成物
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US5972980A (en) * 1995-10-05 1999-10-26 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
AU6966696A (en) * 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
DE10210779A1 (de) * 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
US7270805B1 (en) * 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists
JP5964965B2 (ja) * 2011-08-18 2016-08-03 ドクター レディズ ラボラトリーズ リミテッド コレステリルエステル転送タンパク質（ｃｅｔｐ）インヒビターとしての置換複素環式アミン化合物
US9199948B2 (en) * 2012-05-21 2015-12-01 Dr. August Wolff Gmbh & Co. Kg Arzneimittel 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics
EP3932395A1 (en) * 2020-07-03 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Stable emulsion containing an active pharmaceutical ingredient based on n(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)dodecanamide, production and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663972A (en) * 1979-10-30 1981-05-30 Tetsujirou Masuko Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt
DE3017977A1 (de) * 1980-05-10 1981-11-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte 2(3h)-benzothiazolone
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8325370D0 (en) * 1983-09-22 1983-10-26 Fujisawa Pharmaceutical Co Benzoxazoline and benzothiazoline derivatives
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
CA1305151C (en) 1992-07-14
DK288287D0 (da) 1987-06-04
ZA874046B (en) 1989-01-25
SU1757464A3 (ru) 1992-08-23
CN87104099A (zh) 1988-02-10
YU104987A (en) 1988-08-31
YU45423B (en) 1992-05-28
KR880000413A (ko) 1988-03-25
FI87924B (fi) 1992-11-30
GR3001584T3 (en) 1992-11-23
AU7387887A (en) 1987-12-10
NO872382L (no) 1987-12-10
PT85035B (pt) 1990-03-08
NO872382D0 (no) 1987-06-05
NO168246B (no) 1991-10-21
FI872555A (fi) 1987-12-10
AU586337B2 (en) 1989-07-06
HU198451B (en) 1989-10-30
IE871505L (en) 1987-12-09
PT85035A (en) 1987-07-01
JPS63107958A (ja) 1988-05-12
DD265141A5 (de) 1989-02-22
DE3767778D1 (de) 1991-03-07
EP0249407B1 (en) 1991-01-30
PL150631B1 (en) 1990-06-30
EP0249407A2 (en) 1987-12-16
ATE60596T1 (de) 1991-02-15
DK288287A (da) 1987-12-10
HUT48209A (en) 1989-05-29
FI872555A0 (fi) 1987-06-08
IE60015B1 (en) 1994-05-18
NO168246C (no) 1992-01-29
FI87924C (fi) 1993-03-10
KR900000552B1 (ko) 1990-01-31
JPH0623199B2 (ja) 1994-03-30
CN1015334B (zh) 1992-01-29
EP0249407A3 (en) 1988-10-19
PL266132A1 (en) 1988-06-23

Similar Documents

Publication Publication Date Title
ES2031892T3 (es) Agentes antialergicos y antiinflamatorios.
DE3772015D1 (de) Chinolinverbindung.
FI861506A (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
ATE73759T1 (de) Fungizide.
ES2060964T3 (es) Nuevos compuestos de benzoxazolona y su utilizacion como microbicidas.
ATE53833T1 (de) Derivate des phenylacetanilids.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE52514T1 (de) S-aralkyltrithiophosphonat-insektizide.
ES2015297B3 (es) Herbicidas de fenilurea.
AU557502B2 (en) Dithiino(1,4)(2,3-c)pyrrole derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 249407

Country of ref document: ES

FG2A Definitive protection

Ref document number: 0249407

Country of ref document: ES